Indicators of homologous recombination deficiency in breast cancer and association with response to neoadjuvant chemotherapy.
Lips
E H
EH
Departments of Experimental Therapy; Pathology, The Netherlands Cancer Institute.
Mulder
L
L
Departments of Experimental Therapy; Pathology, The Netherlands Cancer Institute.
Hannemann
J
J
Departments of Experimental Therapy.
Laddach
N
N
MRC-Holland.
Vrancken Peeters
M T F D
MTFD
Department of Surgical Oncology, The Netherlands Cancer Institute.
van de Vijver
M J
MJ
Departments of Experimental Therapy; Pathology, The Netherlands Cancer Institute; Department of Pathology, Academic Medical Center.
Wesseling
J
J
Pathology, The Netherlands Cancer Institute.
Nederlof
P M
PM
Pathology, The Netherlands Cancer Institute.
Rodenhuis
S
S
Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. Electronic address: s.rodenhuis@nki.nl.